Stay updated on FLT3 Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.

Latest updates to the FLT3 Inhibitor Combo in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page without altering substantive content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now displays an updated platform release version, indicating Revision: v3.6.5 replacing the previous v3.6.4. This reflects a minor site maintenance update and does not alter the study record content.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page now displays the latest release tag Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.0%

- Check51 days agoChange DetectedNew sections Study Status and Study Identification were added to the record history, and a new version entry (106) from 2026-06-23 was introduced along with an update on 2026-07-14; the 2025-09-12 entry was removed.SummaryDifference0.2%

- Check72 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.3 and the previous Revision: v3.6.0 is removed from the history, representing a minor metadata update to the record viewer.SummaryDifference0.0%

- Check87 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants,' indicating the study is not enrolling; the history now shows a new revision tag (v3.6.0) replacing the previous one (v3.5.5).SummaryDifference0.1%

Stay in the know with updates to FLT3 Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.